Journal of Arthritis and RheumatologyIn the mean time, baricitinib is utilised below tofacitinib. An all-scenario PMS review of baricitinib analyzed its safety and efficacy profile in Japanese individuals with RA from September 2017 to June 2020. Dietary components and consuming patterns have als